May 2018 - YProtech will be attending Kinases 2018: Towards New Frontiers, 8th RSC/SCI Symposium on Kinase Inhibitor Design

YProtech will be attending the 8th RSC/SCI symposium on kinases in Cambridge on 14th-15th May which will encompass case studies of ongoing programmes as well as successful past programmes. A range of topics including CNS kinase inhibitors, allosteric inhibitors and non-oral delivery methods will be covered, along with views and perspectives on the future of kinase inhibitor research. Find out more here.

May 2018 - YProtech Recruits Additional Experienced Medicinal Chemist

Dr Kelvin Ho joins YProtech as a Research Chemist. An experienced Medicinal Chemist, Kelvin previously worked for several years with a UK based Drug Discovery company. Kelvin’s appointment further strengthens our Medicinal Chemistry expertise and offering to the market.

April 2018 - YProtech Celebrates 3rd Anniversary on Alderley Park Site

It is three years since YProtech relocated from Leeds to Alderley Park and in that time the company has doubled in size. Find out more about our growth and development in the MSP newsletter article here.

April 2018 - YProtech will be presenting at the NEPIC Pharmaceutical Conference: High Potency Processing, Alnwick, 1st May

The conference will cover a number of aspects of high potency processing including categorisation, process development issues, manufacturers’ perspectives, equipment available and engineering design issues. Dr Stuart Brown will present YProtech’s capabilities and expertise in the synthesis of High Potency Compounds. Find out more here.

April 2018 - YProtech attending 29th RSC-BMCS Symposium of Medicinal Chemistry in Eastern England

YProtech will be attending the this long running event held in Hatfield on 26th April. The scientific programme will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemists. Find out more here.